Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 28, 2022
A physiologically based pharmacokinetic model for open acid and lactone forms of atorvastatin and metabolites to assess the drug-gene interaction with SLCO1B1 polymorphismsJavier Reig-López, Matilde Merino-Sanjuan, Alfredo García-Arieta, et al.
Pharmaceutics|June 2, 2021
Current Evidence, Challenges, and Opportunities of Physiologically Based Pharmacokinetic Models of Atorvastatin for Decision MakingJavier Reig-López, Alfredo García-Arieta, Víctor Mangas-Sanjuán, et al.
Pharmaceutics|May 4, 2026
Model-Based Design of Sustained-Release Formulations of Anti-TNF-α Monoclonal Antibodies for Intravitreal AdministrationJavier Reig-López, Marina Cuquerella-Gilabert, Javier Zarzoso-Foj, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 19, 2024
Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomersJavier Reig-López, Marina Cuquerella-Gilabert, Enrique Bandín-Vilar, et al.
Computer Methods and Programs in Biomedicine|November 25, 2023
Phys-DAT: A physiologically-based pharmacokinetic model for unraveling the dissolution, transit and absorption processes using PhysPK®Marina Cuquerella-Gilabert, Javier Reig-López, Jenifer Serna, et al.
Pharmaceutical Statistics|March 10, 2026
Leveraging Two-Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK ModelsMarina Cuquerella-Gilabert, Alessandro De Carlo, Sergio Sánchez Herrero, et al.
Pharmaceutics|October 20, 2020
Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in MiceJavier Reig-López, María Del Mar Maldonado, Matilde Merino-Sanjuan, et al.
International Journal of Pharmaceutics|June 12, 2025
A physiologically based pharmacokinetic model to describe [89Zr]Zr-DFO-Adalimumab specific activity after intravitreal administration to rats with endotoxin-induced uveitisJavier Reig-López, Xurxo García-Otero, Marina Cuquerella-Gilabert, et al.
Pageof 1